Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 05, 2026 07:30 ET | Source: Angitia Incorporated Limited

Angitia Biopharmaceuticals Announces $130 Million Series D Financing

- Financing co-led by Frazier Life Sciences and Venrock Healthcare Capital Partners with significant participation from other new and existing investors - Proceeds will support the ongoing clinical...
January 05, 2026 07:30 ET | Source: Angitia Incorporated Limited

Angitia Biopharmaceuticals Completes Enrollment of Phase 2 ARTEMIS Trial Evaluating AGA2118 for the Treatment of Osteoporosis

- Company expects topline data from the study in 2027 WESTLAKE VILLAGE, Calif., Jan. 05, 2026 (GLOBE NEWSWIRE) -- Angitia Biopharmaceuticals, a clinical-stage biotechnology company focused on the...